Invention Grant
- Patent Title: Modified RSV F proteins and methods of their use
-
Application No.: US14839247Application Date: 2015-08-28
-
Publication No.: US10022437B2Publication Date: 2018-07-17
- Inventor: Peter Pushko , Yingyun Wu , Michael J. Massare , Ye Liu , Gale Smith , Bin Zhou
- Applicant: NOVAVAX, INC.
- Applicant Address: US MD Gaithersburg
- Assignee: NOVAVAX, INC.
- Current Assignee: NOVAVAX, INC.
- Current Assignee Address: US MD Gaithersburg
- Agency: Cooley LLP
- Main IPC: A61K39/155
- IPC: A61K39/155 ; C07K14/005 ; A61K39/12 ; C12N7/00 ; A61K9/00 ; A61K39/39 ; A61K9/107 ; A61K39/00
Abstract:
The present invention is generally related to modified or mutated respiratory syncytial virus fusion (F) proteins and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of RSV infection.
Public/Granted literature
- US20150359872A1 MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE Public/Granted day:2015-12-17
Information query
